MARATTO

erratum · Frontiers in Immunology

Corrigendum: The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy

2024Open accessMansoura University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1127358.].

Research topics

  • Peroxisome Proliferator-Activated Receptors

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3389/fimmu.2024.1422261

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.